Last edited by Vucage
Tuesday, November 24, 2020 | History

3 edition of Legal liability and quality assurance in newborn screening found in the catalog.

Legal liability and quality assurance in newborn screening

Legal liability and quality assurance in newborn screening

  • 284 Want to read
  • 17 Currently reading

Published by American Bar Foundation, Additional copies available from National Center for Education in Maternal & Child Health, Georgetown University in Chicago, Washington, D.C .
Written in English

    Places:
  • United States
    • Subjects:
    • Tort liability of hospitals -- United States -- States -- Congresses.,
    • Medical screening -- Law and legislation -- United States -- States -- Congresses.,
    • Infants (Newborn) -- Diseases -- Law and legislation -- United States -- States -- Congresses.,
    • Phenylketonuria -- Law and legislation -- United States -- States -- Congresses.,
    • Metabolism, Inborn errors of -- Law and legislation -- United States -- States -- Congresses.

    • Edition Notes

      Statementedited by Lori B. Andrews.
      ContributionsAndrews, Lori B., 1952-, American Bar Foundation., United States. Bureau of Health Care Delivery and Assistance. Division of Maternal and Child Health., Conference on Legal Liabilities in Newborn Screening (1984 : Chicago, Ill.)
      Classifications
      LC ClassificationsKF3825.3.Z95 L44 1985
      The Physical Object
      Pagination242 p. :
      Number of Pages242
      ID Numbers
      Open LibraryOL2558431M
      ISBN 100910059063
      LC Control Number85072488
      OCLC/WorldCa13424048

      Decide and describe which pediatric audiology protocols you will initialize to assure quality patient/client/student care. Justify the motivation of your chosen protocols by interweaving literature citations. Some issues relevant to establishing a universal newborn hearing screening program. J. Am. Newborn hearing screening: Issues in.


Share this book
You might also like
The Olympia Press (Paris, 1953-1965)

The Olympia Press (Paris, 1953-1965)

Concorde: the story, the facts and the figures

Concorde: the story, the facts and the figures

You and Your Refugee Neighbor

You and Your Refugee Neighbor

Analogies of organized beings.

Analogies of organized beings.

Sutras and shadows.

Sutras and shadows.

Title insurance in 1984

Title insurance in 1984

Peptide Hormones

Peptide Hormones

The principles of scientific management

The principles of scientific management

Dynamic stability of space vehicles.

Dynamic stability of space vehicles.

Esprits Graphic Work 1984-1986

Esprits Graphic Work 1984-1986

concise guide to tracing your ancestry

concise guide to tracing your ancestry

Excel 4.0 projects for Windows

Excel 4.0 projects for Windows

Northwest wagons

Northwest wagons

Codex Alimentarius

Codex Alimentarius

Famous American fortunes and the men who have made them

Famous American fortunes and the men who have made them

The Resourcing Puzzle

The Resourcing Puzzle

Roman art and architecture..

Roman art and architecture..

Legal liability and quality assurance in newborn screening Download PDF EPUB FB2

Get this from a library. Legal liability and quality assurance in newborn screening. [Lori B Andrews; American Bar Foundation.; United States. Bureau of Health Care Delivery and Assistance. Division of Maternal and Child Health.;] -- Papers from the Conference on Legal Liabilities in Newborn Screening, held in Chicago, Ill., May, which was sponsored by the American Bar Foundation.

©— Bioethics Research Library Box Washington DC   Newborn hearing screening. Issues in legal liability and quality assurance. Linda B. Rose; Linda B. Rose. Louisiana Office of Public Health, New Orleans, LA. The identification of hearing impairment in infants law, section 1.

Chapter A of Louisiana Revised Statutes of Author: Linda B. Rose. Universal screening for infant hearing impairment: Not simple, not risk-free, not necessarily beneficial, and not presently justified.

Pediatrics, 93 (2), – Google ScholarCited by: Newborn Screening Quality Assurance Program CF DNA Proficiency Testing (PT) Program Each participating laboratory received 5 blind-coded profi-ciency testing specimens 4 times a year, and laboratories reported both the genotyping results and clinical assessments to CDC.

These results were evaluated based on the program’s. Legal & Legislative Issues in Newborn Screening APHL collaborates with state newborn screening programs and legal counsels to monitor legal and legislative issues affecting state newborn screening programs.

It conducts these activities through the Legal and Legislative Issues in Newborn Screening Workgroup. Residual newborn screening dried blood samples (DBS) can be used for newborn screening program operations, such as quality assurance and quality control, (p.

) public health surveillance, and public health and biomedical research (Olney et al., ). Since newborn screening is performed on almost all of the babies born in the United States.

Newborn screening identifies conditions that can affect a child’s long-term health or survival. CDC’s Newborn Screening and Molecular Biology Branch manages the Newborn Screening Quality Assurance Program (NSQAP) to enhance and maintain the quality and accuracy of newborn screening results.

The program provides training, consultation, proficiency testing, guidelines, and. The Newborn Screening Saves Lives Act, signed into law in and updated and reauthorized inplays a major role in structuring this federal assistance to state programs.

There is public controversy over the long-term storage and use of newborn screening blood spots in research. JOURNAL OF LAW AND HEALTH newborn screening appears to be neither efficient nor ethically defensible. This Legal Liability and Quality Assurance in Newborn Screening, AMERICAN BAR FOUNDATION (Lori B.

Andrews, ed. JOURNAL OF LAW AND HEALTH. results, and is responsible for quality improvement of the entire newborn screening system. NewSTEPs has adopted a set of Quality Indicators initially developed by stakeholders from the newborn screening community.

NewSTEPs will implement these Quality Indicators to partner with state newborn screening programs to improve their systems. Newborn Screening S36 Legal Liability and Quality Assurance in Newborn Screening (, pp.) B63 Newborn Screening for Genetic-Metabolic Diseases: Progress, Principles and Recommendations (, 22 pp.) S35 State Laws and Regulations Governing Newborn Screening (, pp.) 5.

Quality Assurance The recommendations in this statement do not indicate an iar with the monograph, Legal Liability and Quality Assurance in Newborn Screening, Lori B. Andrews, JD (ed),which can be obtained from the National Center for Education in Maternal and Child Health, Georgetown University, 38th and R.

B.L. Andrews, Legal Liability and Quality Assurance in Newborn Screening () American Bar Association Chicago 4. B.L. Andrews, State Laws and Regulations Governing Newborn Screening () American Bar Association Chicago 5. N.R.M. Buist, Laboratory aspects of newborn screening for metabolic disorders Laboratory Medicine () 2 Legal liability and Quality Assurance in Newborn Screening.

American Bar Foundation, Chicago, 3 Cuckle, HS and Wald. NJ () Maternal serum alpha-fetoprotein measurement: a screening test for Down's syndrome. Lancet, i, – 4 National Committee for Clinical Laboratory Standards. Nomenclature and Definitions for Use in.

TITLE: Newborn Screening Program; DESCRIPTION: Newborn screening (NBS) is an essential public health strategy that enables the early detection and management of several congenital disorders, which if left untreated, may lead to mental retardation and/or diagnosis and initiation of treatment, along with appropriate long-term care help ensure normal growth and development of the.

Cost effectiveness of prenatal screening for neural tube defects. in Prenatal Screening, Policies, and Values: The Example of Neural Tube Defect. Quality Assurance in the Newborn Screening Laboratory: Approved December Recognizes the intense efforts to assure and sustain the highest quality of testing possible for newborn screening (NBS) for public health programs.

Strongly supports the tenets of continuous quality improvement through internal and external quality assurance activities. Legal liability and quality assurance in newborn screening.

American Bar Founda- tion, Chicago, ; 3 Newborn Screening for Sickle Cell Disease and Other Hemoglobinopathies. JAMA, ; 4 Recommendations for Screening Priorities - Australasia. Andrews LB, editor. Legal liability and quality assurance in newborn screening.

Chicago: American Bar Foundation, TABLES & FIGURES. Figure 1. The number of participants for components of the quality assurance program in Figure 2. Comparison of mean reported concentrations by method for phenylalanine quality control materials.

This chapter discusses quality assurance (QA) for newborn screening programs. It describes the Newborn Screening Quality Assurance Program (NSQAP) at the CDC in Atlanta, Georgia, which provides services for laboratories that use specimens of dried-blood spots (DBSs) to perform newborn screening tests.

The mission of this program is to improve interlaboratory comparability and to work. cost for newborn screening, including education, confirmation, follow-up, and management. GENERAL REFERENCES Andrews LB: Legal Liability and Quality Assurance in Newborn Screening. Chicago, American Bar Foundation, Andrews LB: State Laws and Regulations Governing Newborn Screening.

Chicago, American Bar Foundation, Lori B. Andrews, J.D., a research fellow at the American Bar Foundation and a senior scholar at the Center for Clinical Ethics at the University of Chicago, is the author of numerous articles and books including Legal Liability and Quality Assurance in Newborn Screening () and Medical Genetics: A Legal Frontier ().

She has written extensively on issues related to newborn screening and. Legal Liability and Quality Assurance in Newborn Screening. Maternal phenylketonuria a cause of mental retardation in children without the metabolic defect. McKaw BK: Chromosome instabilitysyndromes. Medical Genetics: A Legal Frontier.

Newborn Screening Quality Assurance Program Centers for Disease Control and Prevention (CDC) Buford Highway NE, MS/F43 Atlanta, GA Phone: Fax: Email: [email protected] This program is cosponsored by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories.

The problems of PKU screening continue. In the American Bar Foundation examined the problem of legal liability in newborn screen- ing.~6 It concluded that failure of quality control often increased the likelihood of screening errors and, consequently, of legal liability.

Newborn screening is the largest genetic testing effort in the United States and is considered one of the ten great public health achievements during the first 10 years of the 21st century. For over 35 years, the Newborn Screening Quality Assurance Program (NSQAP) at the US Centers for Disease Control and Prevention has helped NBS laboratories ensure that their testing does not delay diagnosis.

Historically, newborn screening has been based on the analysis of dried-blood spots (DBS) within centralized public health laboratories. Incorporation of newborn screening within state public health systems has provided authority for universal population-based screening with centralized laboratory analyses and quality assurance.

Newborn screening (NBS) is a public health program of screening in infants shortly after birth for conditions that are treatable, but not clinically evident in the newborn period. The goal is to identify infants at risk for these conditions early enough to confirm the diagnosis and provide intervention that will alter the clinical course of the disease and prevent or ameliorate the clinical.

Anne Marie Tharpe, Ellen Wright Clayton, Newborn Hearing Screening: Issues in Legal Liability and Quality Assurance, American Journal of Audiology ; 6: Gerald B. Hickson, James Pichert, Charles Federspiel, Ellen Wright Clayton, Development of an Early Identification and Response Model of Malpractice Prevention, Law and.

Newborn Screening Annual Report Quality Assurance and Development Activities Inthe Washington State Newborn Screening Program participated in several new educational activities. Partnering with Western States Genetics Collaborative, it helped administer a survey at Savvy. Laboratory Quality Assurance Programs.

Skip Navigation. Newborn Screening Quality Assurance Program. NSQAP Home: About the Program: Program Operations: Program Services: Applications of Bloodspot Technology: Reports: Partners & Related Links: Resources: Contact Us: View Public Reports.

Newborn Screening Quality Improvement Initiatives: Background Prior to the November MJS article, all of the interviewed states had already begun some NBS quality assurance or quality improvements efforts, but the article allowed states to refocus on NBS processes, especially within the context of blood sample transit times.

Total quality management should be applied to newborn screening programs. As with any programmatic effort, improvements result from careful and continuous monitoring of key steps in the process, the assessment of that information, and the introduction of changes external quality assurance and is interrelated with quality control.

Regulating Reproductive Technologies, 21 The Journal of Legal Medicine 35 () (with N. Elster). Book Review, The New England Journal of Medicine () (reviewing R.

Chadwick et al. eds., The Ethics of Genetic Screening ()). (Editor) Legal Liability and Quality Assurance in Newborn Screening, American Bar Foundation (Chicago, IL), State Laws and Regulations Governing Newborn Screening, American Bar Foundation (Chicago, IL), Between Strangers: Surrogate Mothers, Expectant Fathers, and Brave New Babies, Harper & Row (New York, NY), Georgia Newborn Screening Program: Policy and Procedure Manual Introduction Newborn Screening (NBS) is a population-based screening program that prevents the morbidity and mortality outcomes of certain conditions and disorders on the NBS panel.

NBS began in when Dr. Legal liability and quality assurance in newborn screening / edited by Lori B. Andrews. KF Z95 L44 Hospital liability, / Henry B.

Alsobrook, chairman. check for newborn screening results. This is a quality assurance approach that verifies that all babies have been screened (rather than assuming “no news is good news”).

This will help pediatricians to know who has been screened and will enable office staff to get results and follow up appropriately.

Baby's First Test This Web site, produced by the Genetic Alliance and partners with support from the HRSA/MCHB, is a newborn screening information resource center—specifically for parents and the public—based on legislation (the Newborn Screening Saves Lives Act). The site aims to expand support, research, and education opportunities.

Newborn screening, which represents one of the major advances in child health of the past century, has been carried out in all fifty U.S. states since the s. Newborn screening programs are stat.); Randall R.

Bovbjerg, Mtedical Malpractice on Trial: Quality of Care Is the Important Standard, 49 L & Contemp Probs (Spring ); George L. Priest, The Current Insurance Crisis and Modern Tort Law, 96 Yale LJ (). 2. See, for example, Institute of Medicine, Medical Professional Liability and the Delivery of.An investigation was undertaken to determine whether mothers whose infants failed a newborn hearing screening A book of resources (pp.

–). Lanham, MD: Scarecrow Press. Issues in legal liability and quality assurance. American Journal of Audiology, 6(2).